Titan Pharmaceuticals earnings were -$4.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TTNP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$790.0k, up 3.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TTNP reported annual earnings of -$4.7M, with -15.5% growth.
Titan Pharmaceuticals Earnings Reports & History FAQ
What were Titan Pharmaceuticals's earnings last quarter?
Titan Pharmaceuticals (NASDAQ: TTNP) reported Q4 2024 earnings per share (EPS) of -$0.85, up 67.56% year over year. Total TTNP earnings for the quarter were -$790.00 thousand. In the same quarter last year, Titan Pharmaceuticals's earnings per share (EPS) was -$2.62.
Is Titan Pharmaceuticals profitable or losing money?
As of the last Titan Pharmaceuticals earnings report, Titan Pharmaceuticals is currently losing money. Titan Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$4.71 million, a 15.5% decrease year over year.
What was TTNP's earnings growth in the past year?
As of Titan Pharmaceuticals's earnings date in Q2 2025, Titan Pharmaceuticals's earnings has grown year over year. TTNP earnings in the past year totalled -$4.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.